Table 1.

Patient characteristics, MDS-UPDRS scores, and coordinates of lead location in the left and right STN.

	Non-GBA (n = 5)	GBA (n = 4)	p-value
Age (years)	60.0 (7.1)	54.0 (8.5)	0.29
Disease duration (years)	9.4 (4.2)	6.3 (2.9)	0.19
Sex	M, 4; F, 1	M, 3; F, 1
Ethnicity (n)	2	3
Caucasian, non-Hispanic	1	1
Caucasian, Hispanic	2	0
Asian	0	0
Other
MDS-UPDRS Part III (OFF medication)	51.8 (13.6)	47.3 (8.3)	1.0
MDS-UPDRS Part III (ON medication)	22.6 (5.3)	29.8 (10.5)	0.41
Bradykinesia asymmetry score	−0.6 (3.5)	7.0 (2.9)	0.01
Left STN
X	−10.6 (1.4)	−9.7 (1.7)	0.56
Y	−4.8 (1.0)	−4.3 (0.7)	0.41
Z	−5.0 (0.8)	−4.8 (0.9)	1.0
Right STN
X	10.5 (1.0)	9.2 (0.2)	0.06
Y	−3.7 (1.6)	−4.4 (0.4)	0.19
Z	−6.3 (1.0)	−5.4 (1.0)	0.19

Mean values (standard deviation) are shown; MDS-UPDRS, Movement Disorders Society Unified Parkinson's Disease Rating Scale; STN, subthalamic nucleus; GBA, Glucocerebrosidase; M, male; F, female.